Fundraising Fox

Syntax

New York, US · New York LLC · 2 known investors

Founders & leadership

PS
Patrick ShaddowExecutive
RB
Rory Balfour RiggsNamed on SEC filing

Board

RP
Richard PhillipsBoard director
BM
Barry Michael FoxBoard director

Investors · 2

Astellas Venture Management LLCreportedSouth San Francisco · $200K – $5M
Walder VenturesreportedChicago

Reported raises · per SEC filings

Form D private placements

$1.7M disclosed across 1 round · 2025

▶$1.7MraisedJan 2026 · 27 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Patrick ShaddowExecutive Officer, Director
  • Richard PhillipsDirector
  • Rory Balfour RiggsDirector
  • Barry Michael FoxDirector
Offering amount
$6M
Amount sold
$1.7M
Minimum investment
$25K
Sales commissions
$360K
Finders' fees
$60K
Proceeds to insiders
$390K
Placement agents
Metric, Metric Financial
First sale
Dec 2025
Incorporated
Limited Liability Company, New York
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Syntax Bio expands funding round to $14.4M, reshuffles leadership team - Crain's Chicago Businesschicagobusiness.com · Jun 2026Syntax Bio Expands Series A to $14.4Mfinsmes.com · Jun 2026Syntax Bio Raises $14.4M for CRISPR Cell Therapyallsci.com · Jun 2026Syntax Bio Announces Expanded Series A and Leadership Appointmentsbusinesswire.com · Jun 2026Syntax Bio Raises Funding | citybizcitybiz.co · Sep 2024Syntax Health Raises $7.5M in Seed Funding | citybizcitybiz.co · Jun 2023

Frequently asked questions

Who are Syntax's investors?
Syntax's investors include Astellas Venture Management LLC, Walder Ventures.
How much funding has Syntax raised?
Syntax has disclosed $1.7M raised across 1 round.
Where is Syntax headquartered?
Syntax is headquartered in New York, US.